# NICE NG238: cardiovascular disease risk assessment and reduction, including lipid modification

Guideline · id `cardio:guideline-nice-ng238` · Cardiovascular Atlas · release `5dcd9b263fe17744` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Risk and prevention; Coronary and vascular disease  

## In plain language

The UK NICE guideline NG238 on assessing and reducing the risk of cardiovascular disease, including lipid modification. Only an NCBI Bookshelf catalogue record was read, so this page gives no recommendations.

## Technical summary

NCBI Bookshelf lists NG238 with a publisher line dated 2023 Dec 14 (series statement NICE Clinical Guidelines, No. 238). That is the date of the Bookshelf copy; the NICE publication and update dates were not read because nice.org.uk was not fetched. NICE content is cite only, so this atlas states what it read in its own words.

## Connected pages

- Issuer: the publisher line of the Bookshelf catalogue record names NICE: National Institute for Health and Care Excellence (`cardio:nice`)

## Provenance

Content hash: fa32e912733c79921fcf8123cb42d73c86aa7f5b9791569842f9ab7cd984ef8a
Last substantive edit: 2026-10-15
Evidence last checked: 2026-10-15